Literature DB >> 31311791

Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma.

Haoyu Sun1,2, Lianxin Liu3, Qiang Huang4, Huan Liu5,2, Mei Huang4, Jiabei Wang3, Hao Wen6, Renyong Lin6, Kun Qu5,2, Kun Li5,2, Haiming Wei5,2, Weihua Xiao5,2, Rui Sun5,2, Zhigang Tian1,2, Cheng Sun1,2,7.   

Abstract

The discovery of CD49a+ liver-resident natural killer (NK) cells in mice alters our view of NK cells and provides another opportunity to study NK cells. Although evidence has suggested roles for NK cells in liver diseases, whether and how CD49a+ NK cells contribute to liver diseases remain unclear. In this study, we observed that accumulation of CD49a+ tissue-resident NK cells in human hepatocellular carcinoma (HCC) was higher than in peritumoral tissues. We studied the exhausted and regulatory phenotypes of CD49a+ tissue-resident NK cells by analysis of protein and mRNA. The proportion of CD49a+ NK cells was positively correlated to the proportion of NK cells expressing inhibitory receptors. In addition, CD49a+ NK cells expressed more of checkpoint molecules PD-1, CD96, and TIGIT. Transcriptomic analysis implicated CD49a+ tissue-resident NK cells in the negative regulation of immune responses. Comparison of murine and human CD49a+ NK cells revealed their distinct characteristics and functions. Finally, accumulation of tissue-resident CD49a+ NK cells in liver tumor was correlated to deteriorating disease condition and poor prognosis. Our findings show that CD49a+ NK cells accumulate in liver tumor and suggest a role for CD49a+ NK cells in the negative regulation of immune responses and the development of HCC. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31311791     DOI: 10.1158/2326-6066.CIR-18-0757

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  32 in total

Review 1.  Tumor-Infiltrating Natural Killer Cells.

Authors:  Beatriz Cózar; Marco Greppi; Sabrina Carpentier; Emilie Narni-Mancinelli; Laura Chiossone; Eric Vivier
Journal:  Cancer Discov       Date:  2020-12-04       Impact factor: 39.397

2.  Role of NK Cells in Tumor Progression.

Authors:  Iñigo Terrén; Francisco Borrego
Journal:  Exp Suppl       Date:  2022

3.  Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.

Authors:  Huan Liu; Ronghua Zhao; Rongrong Qin; Haoyu Sun; Qiang Huang; Lianxin Liu; Zhigang Tian; Björn Nashan; Cheng Sun; Rui Sun
Journal:  Cancer Biol Med       Date:  2022-07-21       Impact factor: 5.347

4.  LFA-1/ ICAM-1 promotes NK cell cytotoxicity associated with the pathogenesis of ocular toxoplasmosis in murine model.

Authors:  Nannan Gao; Chong Wang; Yiran Yu; Linding Xie; Yien Xing; Yuan Zhang; Yanling Wang; Jianjun Wu; Yihong Cai
Journal:  PLoS Negl Trop Dis       Date:  2022-10-07

5.  Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.

Authors:  Hongjun Yu; Chaoqun Wang; Shanjia Ke; Miaoyu Bai; Yanan Xu; Shounan Lu; Zhigang Feng; Baolin Qian; Yue Xu; Menghua Zhou; Zihao Li; Bing Yin; Xinglong Li; Yongliang Hua; Yongzhi Zhou; Shangha Pan; Yao Fu; Yong Ma
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

Review 6.  Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment.

Authors:  Rosalia Busà; Matteo Bulati; Ester Badami; Giovanni Zito; Daniela Claudia Maresca; Pier Giulio Conaldi; Giuseppe Ercolano; Angela Ianaro
Journal:  Front Cell Dev Biol       Date:  2022-05-26

Review 7.  Natural killer cell homing and trafficking in tissues and tumors: from biology to application.

Authors:  Guang He Ran; Yu Qing Lin; Lei Tian; Tao Zhang; Dong Mei Yan; Jian Hua Yu; You Cai Deng
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

Review 8.  Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.

Authors:  Amber G Bozward; Frazer Warricker; Ye H Oo; Salim I Khakoo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

Review 9.  The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.

Authors:  Yicun Jiang; Leilei Zhao; Yiwen Wu; Sijun Deng; Pu Cao; Xiaoyong Lei; Xiaoyan Yang
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 10.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.